Cited by 693Advanced Drug Delivery SystemsRetinal Diseases and TreatmentsOcular Infections and Treatments

The DOI matches its Crossref record; 476 of the 476 references it cites were found in a registry or an index.

Pharmacokinetic aspects of retinal drug delivery

Open access

del Amo, Eva M., Rimpelä, Anna-Kaisa, Heikkinen, Emma, Kari, Otto K., Ramsay, Eva, Lajunen, Tatu, Schmitt, Mechthild, Pelkonen, Laura, Bhattacharya, Madhushree, Richardson, Dominique, Subrizi, Astrid, Turunen, Tiina, Reinisalo, Mika, Itkonen, Jaakko, Toropainen, Elisa, Casteleijn, Marco, Kidron, Heidi, Antopolsky, Maxim, Vellonen, Kati-Sisko, Ruponen, Marika, Urtti, Arto·2017·Progress in Retinal and Eye Research

DOI 10.1016/j.preteyeres.2016.12.001

Open this paper in CoChat — free account Open PDF

Abstract

Drug delivery to the posterior eye segment is an important challenge in ophthalmology, because many diseases affect the retina and choroid leading to impaired vision or blindness. Currently, intravitreal injections are the method of choice to administer drugs to the retina, but this approach is applicable only in selected cases (e.g. anti-VEGF antibodies and soluble receptors). There are two basic approaches that can be adopted to improve retinal drug delivery: prolonged and/or retina targeted delivery of intravitreal drugs and use of other routes of drug administration, such as periocular, suprachoroidal, sub-retinal, systemic, or topical. Properties of the administration route, drug and delivery system determine the efficacy and safety of these approaches. Pharmacokinetic and pharmacodynamic factors determine the required dosing rates and doses that are needed for drug action. In addition, tolerability factors limit the use of many materials in ocular drug delivery. This review article provides a critical discussion of retinal drug delivery, particularly from the pharmacokinetic point of view. This article does not include an extensive review of drug delivery technologies, because they have already been reviewed several times recently. Instead, we aim to provide a systematic and quantitative view on the pharmacokinetic factors in drug delivery to the posterior eye segment. This review is based on the literature and unpublished data from the authors' laboratory.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.preteyeres.2016.12.001

Cites

476 of 476 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.
Boussif, O., Lezoualc’h, F., Zanta, M. A., Djavaheri‐Mergny, M., Scherman, D., DEMENEIX, B. A., & Behr, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,256
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
Wong, W. L., Su, X., Li, X., Cheung, C. M. G., Klein, R., Cheng, C., & Wong, T. Y. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(13)70145-1 · Cited by 5,545
Regulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,958
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Tenzer, S., Docter, D., Kuharev, J., Musyanovych, A., Fetz, V., Hecht, R., Schlenk, F., Fischer, D., Kiouptsi, K., Reinhardt, C., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.181 · Cited by 2,283
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
Maguire, A. M., Simonelli, F., Pierce, E. A., Pugh, E. N., Mingozzi, F., Bennicelli, J., Banfi, S., Marshall, K. A., Testa, F., Surace, E. M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802315 · Cited by 2,145

Flagged first, then by citations

Show all 476 references

Research works printed but not linked: 7

Barza, 1982, The effects of infection and probenecid on the transport of carbenicillin from the rabbit vitreous humor. Investig. Ophthalmol, Vis. Sci., 22, 720
Gisladottir, 2009, Diffusion characteristics of vitreous humour and saline solution follow the Stokes Einstein equation. Graefe's Arch. Clin. Exp, Ophthalmol, 247, 1677
Haselton, 1996, Modulation of retinal endothelial barrier in a perfused cell-column model of the retinal microvasculature, Investig. Ophthalmol. Vis. Sci., 37, 211
Johnson, 1984, vol. 39, 791
Szebeni, 2005, Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity, Toxicology, 216, 106, 10.1016/j.tox.2005.07.023 · DOI
Szebeni, 2011, Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention, Adv. Drug Deliv. Rev., 63, 1020, 10.1016/j.addr.2011.06.017 · DOI
U.S. Food and Drug Administration, 2013, Guidance for industry: immunogenicity assessment for therapeutic protein products, Biotechnol. Law Rep., 172

Sorted by citations

Items 401–500 of 693

Drug Distribution After Intravitreal Injection: A Mathematical Model
Ruffini, A., Casalucci, A., Cara, C., Ethier, C. R., & Repetto, R. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.4.9 · Cited by 7
Mathematical model for degradation and drug release from an intravitreal biodegradable implant
Ferreira, J. A., Gonçalves, M. B., Gudin͂o, E., Maia, M., & Oishi, C. M. (2020) · Computers & Mathematics with Applications · doi:10.1016/j.camwa.2020.09.007 · Cited by 7
New technique and device for controlled and continuous drug delivery into the brain: a proof-of-concept study
Anoop, U. R., & Verma, K. (2021) · BMJ Innovations · doi:10.1136/bmjinnov-2019-000393 · Cited by 7
Every nano-step counts: a critical reflection on do’s and don’ts in researching nanomedicines for retinal gene therapy
Peynshaert, K., Devoldere, J., Smedt, S. C. D., & Remaut, K. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2167979 · Cited by 7
In situ gels: The next new frontier in ophthalmic drug delivery system
Sha, G., Liu, J., Jiang, Z., Zhu, M., Zhu, Y., Gu, C., Qian, Y., & Xi, J. (2023) · Polymers for Advanced Technologies · doi:10.1002/pat.6079 · Cited by 7
Ocular and Plasma Pharmacokinetics of Enavogliflozin Ophthalmic Solution in Preclinical Species
Jang, M., Kang, M., Lee, E., & Shin, D. (2024) · Pharmaceuticals · doi:10.3390/ph17010111 · Cited by 7
Hyaluronic Acid Graft Copolymers with Cleavable Arms as Potential Intravitreal Drug Delivery Vehicles
Borke, T., Najberg, M., Ilina, P., Bhattacharya, M., Urtti, A. O., Tenhu, H. J., & Hietala, S. (2017) · Macromolecular Bioscience · doi:10.1002/mabi.201700200 · Cited by 7
Self-citation
Spectral‐domain optical coherence tomography imaging of normal foveae: A pilot study in 17 diurnal birds of prey
Gomes, F. E., Abou‐Madi, N., Ledbetter, E. C., & McArt, J. A. A. (2020) · Veterinary Ophthalmology · doi:10.1111/vop.12732 · Cited by 7
Size-Exclusive Nanoporous Biodegradable PLGA Capsules for Drug Delivery Implants and In Vivo Stability in the Posterior Segment
He, X., Yuan, Z. J., Kao, W. W. ‐., Miller, D. M., Li, S. K., & Park, Y. C. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00027 · Cited by 7
Avoiding the Pitfalls of siRNA Delivery to the Retinal Pigment Epithelium with Physiologically Relevant Cell Models
Ramsay, E., Raviña, M., Sarkhel, S., Hehir, S., Cameron, N. R., Ilmarinen, T., Skottman, H., Kjems, J., Urtti, A. O., Ruponen, M., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070667 · Cited by 8
Self-citation
Mathematical models for the effect of anti-vascular endothelial growth factor on visual acuity
Edwards, D. A., Emerick, B., Kondic, A. G., Kiradjiev, K., Raymond, C., & Zyskin, M. (2020) · Journal of Mathematical Biology · doi:10.1007/s00285-020-01544-4 · Cited by 7
Antibody Format and Serum Disposition Govern Ocular Pharmacokinetics of Intravenously Administered Protein Therapeutics
Shivva, V., Boswell, C. A., Rafidi, H., Kelley, R. F., Kamath, A. V., & Crowell, S. R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.601569 · Cited by 7
Modeling the Effects of Disease, Drug Properties, and Material on Drug Transport From Intraocular Lenses
Clasky, D. P., Meunier, L., & Wells, L. A. (2022) · Translational Vision Science & Technology · doi:10.1167/tvst.11.5.14 · Cited by 7
Doxorubicin-loaded DNA origami nanostructures: stability in vitreous and their uptake and toxicity in ocular cells
Klose, A., Gounani, Z., Ijäs, H., Lajunen, T., Linko, V., & Laaksonen, T. (2024) · Nanoscale · doi:10.1039/d4nr01995d · Cited by 6
Self-citation
A miR-383-5p Signaling Hub Coordinates the Axon Regeneration Response to Inflammation
Hintermayer, M. A., Juźwik, C. A., Morquette, B., Hua, E. M.-L., Zhang, J., Drake, S., Shi, S. S., Rambaldi, I., Vangoor, V. R., Pasterkamp, R. J., et al. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.1822-23.2024 · Cited by 8
Intravitreal Administration of Adalimumab‐Loaded Poly(Lactic‐co‐Glycolic Acid) Nanoparticles: Effects on Biodistribution and Pharmacokinetics
García‐Otero, X., Varela‐Fernández, R., Cuartero‐Martínez, A., Gómez‐Lado, N., González‐Barcia, M., Mondelo‐García, C., Feitosa-Medeiros, C., Aguiar, P., Fernández‐Ferreiro, A., & Otero-Espinar, F. J. (2025) · Small Science · doi:10.1002/smsc.202400494 · Cited by 6
Peptide-based hydrogel co-assembled with antibody-drug for enhanced retinal cell uptake and attenuated experimental autoimmune uveitis
Dai, M., Du, P., Li, Y., Wang, X., Chen, J., Liu, H., Zhang, W., Zhou, J., Li, X., & Wang, Y. (2025) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2025.114691 · Cited by 6
Modified thiomer-based nanomedicines in management of ocular complications: a review
Basu, B., Mallick, S., Dhauria, S., Das, A., & Singh, S. K. (2025) · Biotechnology for Sustainable Materials · doi:10.1186/s44316-025-00027-0 · Cited by 6
Systemic exposure following intravitreal administration of therapeutic agents: an integrated pharmacokinetic approach. 2. THR-687
Vanhove, M., Wagner, J.-M., Noppen, B., Jonckx, B., Vermassen, E., & Stitt, A. W. (2021) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-021-09774-9 · Cited by 6
IMPLICATIONS OF COMPLETE POSTERIOR VITREOUS DETACHMENT IN EYES WITH CENTRAL RETINAL VEIN OCCLUSION
Zheng, Y., Woodward, R., Feng, H. L., Lee, T., Zhang, X., Pant, P., Thomas, A. S., & Fekrat, S. (2023) · Retina · doi:10.1097/iae.0000000000003932 · Cited by 6
Nanostructured Lipid Carriers Mediated Drug Delivery to Posterior Segment of Eye and their In-vivo Successes
Singh, A. K., Kumar, M., & Upadhyay, P. K. (2023) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201025666230907145019 · Cited by 6
Structural optimization of diblock polymers that undergo thermo-responsive nanoparticle self-assembly for intravitreal drug delivery
Fergie, K. J., Wilson, D. R., Kracíková, L., Androvič, L., Yamagata, H. M., Wang, E. B., Yoon, H., Lynn, G. M., & Laga, R. (2024) · European Polymer Journal · doi:10.1016/j.eurpolymj.2024.113054 · Cited by 6
Ocular drug-metabolizing enzymes: focus on esterases
Hammid, A., & Honkakoski, P. (2024) · Drug Metabolism Reviews · doi:10.1080/03602532.2024.2368247 · Cited by 7
Latest trends & strategies in ocular drug delivery
Kulkarni, N. S., Josowitz, A. D., James, R., Liu, Y., Rayaprolu, B. M., Sagdullaev, B. T., Bhalla, A. S., & Shameem, M. (2025) · Methods · doi:10.1016/j.ymeth.2025.02.003 · Cited by 7
Topical Ketotifen Fumarate Inhibits Choroidal Mast Cell Degranulation and Loss of Retinal Pigment Epithelial Cells in Rat Model for Geographic Atrophy
Nizawa, T., Bhutto, I. A., Tiwari, A., Grebe, R. R., Alt, J., Rais, R., Edwards, M. M., & Lutty, G. A. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.14.37 · Cited by 6
Application of an organotypic ocular perfusion model to assess intravitreal drug distribution in human and animal eyes
Chan, D. W.-H., Won, G.-J., Read, A. T., Ethier, C. R., Thackaberry, E. A., Crowell, S. R., Booler, H. S., Bantseev, V., & Sivak, J. M. (2022) · Journal of The Royal Society Interface · doi:10.1098/rsif.2021.0734 · Cited by 6
Suprachoroidal Drug Delivery for Macular Edema Associated With Noninfectious Uveitis
Huang, Y., Choo, C. H., Hancock, S. E., Ciulla, T. A., Wykoff, C. C., Shantha, J. G., & Yeh, S. (2024) · Journal of VitreoRetinal Diseases · doi:10.1177/24741264241246314 · Cited by 6
Ocular delivery systems for the administration of antibody therapeutics
Jin, S., & Hwang, S. (2017) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0336-6 · Cited by 6
Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by mutations in USH2A exon 13Preprint
Slijkerman, R., van Diepen, H., Albert, S., Dona, M., Venselaar, H., Zang, J., Neuhauss, S. C. F., Peters, T., Broekman, S., Pennings, R., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.06.320499 · Cited by 6
Impact of Type 2 diabetes mellitus and insulin use on progression to glaucoma surgery in primary open angle glaucoma
Sun, M. T., Pershing, S., Goldberg, J. L., & Wang, S. Y. (2023) · Eye · doi:10.1038/s41433-023-02734-2 · Cited by 5
Revolutionizing uveitis treatment with nanotechnology: Innovations, barriers, and strategic solutions
Johari, M., Baghban, R., Salari, R., & Attar, A. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118911 · Cited by 5
Pharmacological principles of intravitreal drug therapy and their implications for clinical practice: a primer for the ophthalmologist
Ezzine, S., Gale, R. P., Bailey, C., Patel, P. J., Sivaprasad, S., Keshk, Z., Eißing, T., Höchel, J., Gilbert, R. M., & Morgan-Warren, P. J. (2026) · Eye · doi:10.1038/s41433-026-04540-y · Cited by 5
Nano-emulsomes for back of the eye delivery of Ganciclovir: formulation optimization, characterization & in vitro/in vivo evaluation
Kapadia, R., Jain, M., Patel, D., Devkar, R., & Sawant, K. K. (2023) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2023.2216784 · Cited by 5
Ex Vivo Pig Eye Model for Studying Diffusion of Acylcarnitines with Different Physicochemical Properties
Hiller, J. K., Sandås, E. M., Rootwelt, H., Vassli, A. Ø., Utheim, T. P., Moe, M. C., Elgstøen, K. B. P., & Petrovski, G. (2023) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2022.0159 · Cited by 5
Transporter Protein Expression of Corneal Epithelium in Rabbit and Porcine: Evaluation of Models for Ocular Drug Transport Study
Ramsay, E., Montaser, A. B., Niitsu, K., Urtti, A., Auriola, S., Huttunen, K., Uchida, Y., Kidron, H., & Terasaki, T. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c01210 · Cited by 6
Self-citation
Ocotillol Derivatives Mitigate Retinal Ischemia-Reperfusion Injury by Regulating the Keap1/Nrf2/ARE Signaling Pathway
Zhang, X., Zhang, W., Zhao, L., Ma, G., Huang, Y., Geng, Z., Jiang, Q., Wen, X., Lin, Y., Meng, Q., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00867 · Cited by 5
Polymer-free tacrolimus microsphere implants for long-acting prevention of corneal neovascularization in rats by subconjunctival injection
Liu, J., Yang, H., & Xia, D. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114043 · Cited by 5
Uptake and pharmacokinetics of cefuroxime in rabbits after intravitreal, intracameral, and topical dosing: relevance to human ocular injection of cefuroxime
Jairam, R. K., Mallurwar, S. R., Gabani, B. B., Zakkula, A., Kiran, V., Dittakavi, S., Sulochana, S. P., Zainuddin, M., Srinivas, N. R., & Mullangi, R. (2019) · Xenobiotica · doi:10.1080/00498254.2019.1624872 · Cited by 5
Steering the Clinical Translation of Delivery Systems for Drugs and Health Products
Pignatello, R., & Matricardi, P. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12040350 · Cited by 6
Inhibition of prolyl oligopeptidase: A promising pathway to prevent the progression of age-related macular degeneration
Hellinen, L., Koskela, A. K. J., Vattulainen, E., Liukkonen, M., Wegler, C., Treyer, A., Handin, N., Svensson, R., Myöhänen, T. T., Poso, A., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112501 · Cited by 5
Self-citation
Exploration of the Plausible Mechanism of Ethambutol Induced Ocular Toxicity by Using Proteomics Informed Physiologically Based Pharmacokinetic (PBPK) Modeling
Balhara, A., Ladumor, M. K., Nankar, R. P., Syed, S. D., Giri, S., Prasad, B., & Singh, S. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03227-9 · Cited by 5
Safety of simultaneous bilateral intravitreal versus unilateral anti-vasculo-endothelial growth factors injection in an operating room setting
Jeeva, I. K., Masud, S., Siddiqui, M. A. R., & Fahad, H. M. (2022) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.38.8.5125 · Cited by 5
Comparison of barrier properties of outer blood-retinal barrier models – Human stem cell-based models as a novel tool for ocular drug discovery
Hellinen, L., Hongisto, H., Ramsay, E., Kaarniranta, K., Vellonen, K., Skottman, H., & Ruponen, M. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2023.01.026 · Cited by 5
Self-citation
Ex Vivo Rat Eye Model for Investigating Transport of Next Generation Precision-Polyester Nanosystems
Ganugula, R., Arora, M., & Kumar, M. N. V. R. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b07896 · Cited by 5
Chromatographic bioanalysis of antiglaucoma drugs in ocular tissues
da Silva, P. H. R., Silva‐Cunha, A., Pianetti, G. A., & Fernandes, C. (2020) · Journal of Chromatography B · doi:10.1016/j.jchromb.2020.122388 · Cited by 5
New Ocular Drug Delivery Systems
Kang‐Mieler, J. J., Rudeen, K. M., Liu, W., & Mieler, W. F. (2020) · Springer eBooks · doi:10.1007/978-981-15-7644-7_41 · Cited by 5
Systemic Drug Delivery to the Posterior Segment of the Eye: Overcoming Blood–Retinal Barrier Through Smart Drug Design and Nanotechnology
Ranganath, S. H., Thanuja, M. Y., Anupama, C., & Manjunatha, T. D. (2020) · Gels horizons: from science to smart materials · doi:10.1007/978-981-15-7998-1_6 · Cited by 6
Protective effect of gypenoside LXXV from Gynostemma pentaphyllum against oxidative stress-induced retinal degeneration in vitro and in vivo
Kim, D. Y., Lee, K. W., & Kim, J. (2021) · Phytomedicine Plus · doi:10.1016/j.phyplu.2021.100050 · Cited by 5
A Comprehensive Review on COVID-19: Emphasis on Current Vaccination and Nanotechnology Aspects
Dewangan, H. K., Rai, A., Shah, K., & Sharma, R. (2022) · Recent Patents on Nanotechnology · doi:10.2174/1872210516666220819104853 · Cited by 5
Fate of the Fc fusion protein aflibercept in retinal endothelial cells: competition of recycling and degradation
Deissler, H. L., Lang, G. K., & Lang, G. E. (2018) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-018-4166-7 · Cited by 6
Trojan Microparticles Potential for Ophthalmic Drug Delivery
Esteban-Pérez, S., Bravo‐Osuna, I., Andrés‐Guerrero, V., Molina-Martínez, I. T., & Herrero‐Vanrell, R. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190905150331 · Cited by 5
Challenges and Innovations of Controlled Drug Delivery
Benson, H. A., & Roberts, M. S. (2021) · doi:10.1002/9781119769644.ch1 · Cited by 5
Topical delivery of anti-VEGF macromolecules for retinopathy: A review
Regu, V. R., Swain, R. P., Pattnaik, L., & Subudhi, B. B. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144151 · Cited by 4
Liposome Encapsulation Enhances Ripasudil Therapeutic Efficacy Against Proliferative Vitreoretinal Diseases: Implications in Advanced Ocular Treatment
Ji, R., Ishikawa, K., Tan, W., Mori, K., Tsukamoto, R., Matsunaga, N., Kiyohara, K., Fukuda, Y., Wada, I., Isobe, T., et al. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.6.56 · Cited by 5
Silver nanoparticles: a new frontier in ophthalmic innovation and treatment
Wang, T., Cao, J., Gan, F., Zhang, Y., & You, Z. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2571060 · Cited by 4
Visible light degradable micelles for intraocular corticosteroid delivery
Qi, R., Mundy, E., & Amsden, B. G. (2024) · Journal of Materials Chemistry B · doi:10.1039/d3tb02793g · Cited by 4
Modeling the Ocular Pharmacokinetics and Pharmacodynamics of Ranibizumab for Improved Understanding and Data Collection Strategies in Ocular Diseases
Crawshaw, J. R., Gaffney, E. A., Gertz, M., Maini, P. K., & Caruso, A. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.6.20 · Cited by 4
Thermal Effects on Fluid Mixing in the Eye
Huang, J., & Gharib, M. (2020) · Annals of Biomedical Engineering · doi:10.1007/s10439-020-02534-9 · Cited by 4
Retinal safety and toxicity study of artesunate in vitro and in vivo
Lu, B.-W., Liang, Y., Liu, J., Sun, Z., So, K., & Chiu, K. (2022) · Advances in Ophthalmology Practice and Research · doi:10.1016/j.aopr.2022.11.003 · Cited by 4
Decreased Expression of Soluble Epoxide Hydrolase Suppresses Murine Choroidal Neovascularization
Park, B., Pasha, S. P. B. S., Sishtla, K. L., Hartman, G. D., Qi, X., Boulton, M. E., & Corson, T. W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415595 · Cited by 4
Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor
Lin, T., Hsieh, Y., Garg, S. J., Chen, L.-J., Chen, K., Wu, W., Lai, C., Hwang, Y., & Kang, E. Y. (2023) · Ophthalmology and Therapy · doi:10.1007/s40123-023-00659-3 · Cited by 4
In Vivo Electroporation Improves Retinal Delivery of Intravitreally Injected Exosomes
Hwang, J. S., Kim, J., You, G. E., Hong, I. H., Cho, I. H., Song, H. B., Shin, Y. J., & Ma, D. J. (2023) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2023.0016 · Cited by 4
Physiologically based pharmacokinetic models for systemic disposition of protein therapeutics in rabbits
Jairam, R. K., Franz, M., Hanke, N., & Kuepfer, L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1427325 · Cited by 5
Diffusion Coefficients of Coated Plasmonic Nanoparticles in Viscous Environment
Largillière, I., Sullivan, D., & Michel Meunier, A. (2024) · Small · doi:10.1002/smll.202404389 · Cited by 4
Advancements in Ocular Modelling and Simulations: Key Considerations and Case Studies
Khan, M. S., Murthy, A. N., & Ahmed, T. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-03001-7 · Cited by 4
Effect of Combination Use of Aqueous Humor Secretion Inhibitor Eye Drops on Aflibercept Level: A Preliminary Analysis
Inoda, S., Takahashi, H., Takahashi, R., Hashimoto, Y., Yoshida, H., Takahashi, H., Fujino, Y., Aizawa, K., Kawashima, H., & Yanagi, Y. (2025) · Translational Vision Science & Technology · doi:10.1167/tvst.14.2.21 · Cited by 4
Intravitreal Pharmacokinetic Study of the Antiangiogenic Glycoprotein Opticin
del Amo, E. M., Griffiths, J. R., Klaska, I. P., Hoke, J., White, A. E., Aarons, L. J., Cooper, G. J. S., Bainbridge, J. W., Bishop, P. N., & Unwin, R. D. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00151 · Cited by 4
Retinal and Lens Degeneration in New Zealand White Rabbits Administered Intravitreal TSG-6 Link Domain-Rabbit FAb Fusion Proteins
Laing, S. T., Tassew, N. G., Tesar, D. B., Wang, Y., Crowell, S. R., Gray, J., Kwong, M., Loyet, K. M., Andaya, R., Kusi, A., et al. (2020) · Toxicologic Pathology · doi:10.1177/0192623320969124 · Cited by 4
Enterococcus gallinarum endophthalmitis and meningitis in an allogeneic hematopoietic stem cell transplant patient: A case report and literature review
Friedman, D. Z. P., Chesdachai, S., Shweta, F., & Mahmood, M. (2021) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi-2021-0016 · Cited by 4
Ocular Injection Techniques for Retinitis Pigmentosa: Intravitreal, Subretinal, and Suprachoroidal
Scherbakova, I., Ragi, S. D., & Sharma, T. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2651-1_34 · Cited by 4
Protein Drug Delivery Using a Novel Maxillofacial Technique Targeting the Visual Pathway in the Brain, the Optic Nerve, and the Retina
Rajendran, R., Arunachalam, J. P., Chidambaram, S., Srikanth, K., Krishnamurthy, B., Vinayagam, S., Veeravarmal, V., Prasad, H., Verma, K., & Anoop, U. R. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00184 · Cited by 4
Topical Solution for Retinal Delivery: Bevacizumab and Ranibizumab Eye Drops in Anti-Aggregation Formula (AAF) in Rabbits
Giannos, S. A., Kraft, E. R., Luisi, J. D., Schmitz-Brown, M., Reffatto, V., Merkley, K. H., & Gupta, P. K. (2024) · Pharmaceutical Research · doi:10.1007/s11095-024-03721-2 · Cited by 5
Toward a Precision Ophthalmology: Targeting the Retina
Ferreira, J. A., de Oliveira, P., da Silva, P. M., & da Silva, R. M. (2018) · SIAM Journal on Applied Mathematics · doi:10.1137/17m1163165 · Cited by 4
Recent Developments for the Treatment of Glaucoma
Adams, C. M., & Papillon, J. P. N. (2020) · Topics in medicinal chemistry · doi:10.1007/7355_2019_92 · Cited by 4
Evaluation of Static and Dynamic Pupil and Light Sensitivity to a Single Drop of Various Concentrations of Low-Dose Atropine (0.01%, 0.025%, and 0.05%)
Alanazi, M., Al-Mansour, A. I., Almutairi, S. S., Alharbi, A., Alhazmi, M., Almustanyir, A., Altoaimi, B. H., Almutairi, M. S., Alamri, M. M., & Liu, M. (2025) · Life · doi:10.3390/life15020278 · Cited by 3
Suprachoroidal Injection of Topotecan for Retinoblastoma: A Preclinical Study
Singh, A. D., Raval, V. R., Kumar, U., & Daniels, A. B. (2025) · Ophthalmology Science · doi:10.1016/j.xops.2025.100875 · Cited by 3
Dual-functionalized mesoporous silica nanoparticles for topical axitinib delivery to the posterior eye segment
Xu, L., Chen, Z.-A., Wu, C.-H., Chen, Y., Wu, S., Mou, C., Tseng, C., Chien, Y., Chan, H. W.-H., Yang, T., et al. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107398 · Cited by 3
Biologics-device combinations: Enabling prolonged therapies in the posterior segment ocular disease
Zhu, S., Zhang, J., Jiang, X., Peng, C., Liu, H., & Qian, F. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115773 · Cited by 3
Molecular Portraits of Aqueous Humor in Primary and Pseudoexfoliative Open-Angle Glaucoma
Shebardina, N. G., Petrov, S. Y., Иомдина, Е. Н., Novikova, N. N., Goriainov, S. V., Александрович, И. В., Zhuravleva, A. N., Tulush, S. S., Shishkin, M. L., Gorbatenko, V. O., et al. (2026) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00982 · Cited by 3
In-Depth Analysis of the Intravitreal Biocompatibility of Polyethylene Glycol of Different Molecular Weight in an In Vivo Porcine Model
Hammer, M., Geisweid, L., Junker, N., Wohlfart, S., Skrzypczyk, L., Ackermann, B. C., Herth, J., Studier‐Fischer, A., Mier, W., Auffarth, G. U., et al. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.2.37 · Cited by 3
Implantable ocular therapeutic systems: an insight into their clinical potential in the long-term treatment of ocular diseases
Kim, H., Kang, N.-W., Hong, W., Abdollahramezani, S., Ngo, G.-H., Raja, D., Peters, O., Mahajan, V. B., Myung, D. J., & DeBoer, C. M. T. (2026) · Biofabrication · doi:10.1088/1758-5090/ae49fe · Cited by 3
Retinal gene therapies for inherited ocular diseases: Translational delivery strategies from bench to bedside
Haddadzadegan, S., Mehdizdeh, N., Wang, X., Wong, T. T. L., & Miserez, A. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114841 · Cited by 3
Applications of Thermoresponsive Hydrogels for Sustained Drug Release in Ocular and Intravitreal Formulations Treating Visual Impairments
Alshahrouri, B., Blass, B. E., Dürig, T., & Fassihi, R. (2026) · The AAPS Journal · doi:10.1208/s12248-026-01253-8 · Cited by 5
Method for siRNA delivery in retina explants
Bassetto, M., Sen, M., Poulhès, F., Arango‐González, B., Ueffing, M., & Zelphati, O. (2023) · Methods in cell biology · doi:10.1016/bs.mcb.2022.12.017 · Cited by 3
Stability of ranibizumab during continuous delivery from the Port Delivery Platform
Hieb, A. R., Horvath, J., Rea, J. C., Tam, T., Chang, D. P., de Jong, I., Zheng, K., Yohe, S. T., & Ranade, S. V. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.12.027 · Cited by 3
Fabrication and appraisal of axitinib loaded PEGylated spanlastics against MCF- 7 and OV- 2774 cell lines using molecular docking methods and in-vitro study
Zaki, R. M., Aldosari, B. N., Al‐Kharashi, L. A., Alsalhi, A., Afzal, O., Alanazi, B. G., Alsunbul, M., Bafail, R., El‐Ela, F. I. A., & Farouk, H. O. (2025) · PLoS ONE · doi:10.1371/journal.pone.0325055 · Cited by 3
Quantifying Hydrolytic Enzymes in the Vitreous Humor of Humans and Nonhuman Species Using Targeted Proteomics
Ruttenberg, S. M., Rowe, J., & Abdolvahabi, A. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00208 · Cited by 3
Core-shell nanotherapeutics for diabetic cataract and retinopathy: current state-of-the-art and translational challenges
Kumari, G., Kundu, S., Famta, P., Kalahasti, K. K., Srivastava, S., Reddy, G. B., & Srinivasarao, D. A. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-025-01971-0 · Cited by 3
Modified cells as potential ocular drug delivery systems
Tennikova, T. B., & Urtti, A. O. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.12.004 · Cited by 3
Self-citation
Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
Sharma, T. P., Curry, S. M., Lohawala, H., & McDowell, C. M. (2020) · Journal of Visualized Experiments · doi:10.3791/61006 · Cited by 3
Dual-acting therapeutic proteins for intraocular use
Collins, M., Awwad, S., Ibeanu, N., Khaw, P. T., Guiliano, D. B., Brocchini, S., & Khalili, H. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.025 · Cited by 3
OFLOXACIN ION PAIRING WITHIN SUBMICRON EMULSION: A POTENTIAL APPROACH FOR OCULAR DELIVERY
Pandey, D., Singh, R., Jain, S., & Jain, D. (2019) · INDIAN DRUGS · doi:10.53879/id.56.04.11490 · Cited by 3
Ocular pharmacokinetics
Chastain, J. E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-819291-7.00005-8 · Cited by 3
Ocular Pharmacokinetic Properties of Intravitreally Injected Aflibercept in Rabbits After Using Brinzolamide/Timolol Eye Drops
Zhou, T., Li, X., Yang, J., Xia, H., Liu, Q., He, J., & Zhang, J. (2023) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2022.0146 · Cited by 3
Imaging ocular water inflow in the mouse with deuterium oxide MRI
Deng, S., Huang, S., Yang, A., & Muir, E. R. (2023) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2023.03.017 · Cited by 3
Mass spectrometry in ocular drug research
del Amo, E. M., Vellonen, K., Urtti, A. O., Terasaki, T., Hammid, A., Honkakoski, P., & Auriola, S. O. K. (2023) · Mass Spectrometry Reviews · doi:10.1002/mas.21861 · Cited by 3
Self-citation
The Link between Economic Growth and Ecological Footprint: What Future Prospects for the G7 Countries: PMG-ARDL
Dardouri, N., & Smida, M. (2023) · MIGRATION LETTERS · doi:10.59670/ml.v20is12.5841 · Cited by 3
Multicompartmental pharmacokinetic evaluation of enavogliflozin eye drop formulation: Understanding its distribution to posterior segments
Cho, S.-J., Kang, D. W., Kim, J. H., Choi, G.-W., Kang, M., & Cho, H. (2024) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-023-00653-8 · Cited by 3
Melanopsin DNA aptamers can regulate input signals of mammalian circadian rhythms by altering the phase of the molecular clock
Nakazawa, K., Matsuo, M., Kikuchi, Y., Nakajima, Y., & Numano, R. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1186677 · Cited by 3
Ocular Drug Delivery: Introduction and Fundamental Concept
Khan, O. F., Bhawale, R., Luthra, K., Srivastava, V., Bansal, K. K., Gupta, V., & Mehra, N. K. (2025) · Springer eBooks · doi:10.1007/978-981-96-6306-4_1 · Cited by 3

Authors: del Amo, E. M., Rimpelä, A.-K., Heikkinen, E., Kari, O. K., Ramsay, E., Lajunen, T., Schmitt, M., Pelkonen, L., Bhattacharya, M., Richardson, D., Subrizi, A., Turunen, T., Reinisalo, M., Itkonen, J., Toropainen, E., Casteleijn, M., Kidron, H., Antopolsky, M., Vellonen, K.-S., Ruponen, M., & Urtti, A.
Affiliations: University of Helsinki (FI)
University of Eastern Finland (FI)
ORCID: Rimpelä, Anna-Kaisa
Heikkinen, Emma
Kari, Otto K.
Ramsay, Eva
Lajunen, Tatu
Pelkonen, Laura
Bhattacharya, Madhushree
Subrizi, Astrid
Reinisalo, Mika
Itkonen, Jaakko
Toropainen, Elisa
Casteleijn, Marco
Kidron, Heidi
Vellonen, Kati-Sisko
Ruponen, Marika
Urtti, Arto
Venue: Progress in Retinal and Eye Research
Publisher: Elsevier BV
Published: 2017-03
Volume: 57
Pages: 134-185
ISSN: 1350-9462 (ISSN-L)
DOI: 10.1016/j.preteyeres.2016.12.001
OpenAlex: W2567416294
Cited by: 693
References: 476
Citations by year: 2026: 68 · 2025: 96 · 2024: 76 · 2023: 92 · 2022: 74 · 2021: 94 · 2020: 81 · 2019: 59 · 2018: 34 · 2017: 18
FWCI: 3.13
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
Locations: Progress in Retinal and Eye Research (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Research Explorer (The University of Manchester) (publishedVersion, other-oa)
UEF eRepo (University of Eastern Finland) (submittedVersion)
Työväentutkimus Vuosikirja (submittedVersion)
Funders: Sigrid Juséliuksen Säätiö (64578)
Itä-Suomen Yliopisto
Academy of Finland (263573, 263615, 268868, 272597, 283721)
Tekes (637/31/2015 TEKES)
Seventh Framework Programme
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
Keywords: retinal drug delivery, pharmacokinetics, intravitreal injection, systemic drug delivery, topical ocular drug delivery, targeted drug delivery, dosage, tolerability, ocular drug delivery systems
MeSH terms: Animals, Humans, Retina, Retinal Diseases, Tissue Distribution, Drug Delivery Systems, Angiogenesis Inhibitors, Intravitreal Injections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pharmacokinetic aspects of retinal drug delivery

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks